Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study.

Journal: The Lancet. Digital health
Published Date:

Abstract

BACKGROUND: Patients have an estimated mortality of 15-20% within the first year following myocardial infarction and one in four patients who survive myocardial infarction will develop heart failure, severely reducing quality of life and increasing the risk of long-term mortality. We aimed to establish the accuracy of an artificial neural network (ANN) algorithm in predicting 1-year mortality and admission to hospital for heart failure after myocardial infarction.

Authors

  • Moman A Mohammad
    Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden. Electronic address: moman.mohammad@med.lu.se.
  • Kevin K W Olesen
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Sasha Koul
    Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
  • Chris P Gale
    Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Rebecca Rylance
    Assistant Director, Health Directorate, School of Health and Society, University of Salford.
  • Tomas Jernberg
    Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Tomasz Baron
    Department of Medical Sciences and Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
  • Jonas Spaak
    Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Stefan James
    Department of Medical Sciences and Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
  • Bertil Lindahl
    Department of Medical Sciences and Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden.
  • Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • David Erlinge
    Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.